[HTML][HTML] Parkinson's disease: A review
DM Radhakrishnan, V Goyal - Neurology India, 2018 - journals.lww.com
Parkinson's disease is a common movement disorder seen in neurological practice, but the
diagnosis and management is challenging. The diagnosis is clinical and sometimes difficult …
diagnosis and management is challenging. The diagnosis is clinical and sometimes difficult …
[HTML][HTML] Freezing of gait in Parkinson's disease: pathophysiology, risk factors and treatments
C Gao, J Liu, Y Tan, S Chen - Translational neurodegeneration, 2020 - Springer
Background Freezing of gait (FOG) is a common, disabling symptom of Parkinson's disease
(PD), but the mechanisms and treatments of FOG remain great challenges for clinicians and …
(PD), but the mechanisms and treatments of FOG remain great challenges for clinicians and …
[HTML][HTML] Levodopa-carbidopa intestinal gel in advanced Parkinson's: final results of the GLORIA registry
Introduction This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa
intestinal gel (LCIG) treatment in advanced Parkinson's disease (PD) patients under routine …
intestinal gel (LCIG) treatment in advanced Parkinson's disease (PD) patients under routine …
[HTML][HTML] Medical management and prevention of motor complications in Parkinson's disease
Levodopa is the most effective medication for the treatment of the motor symptoms of
Parkinson's disease. However, over time, the clinical response to levodopa becomes …
Parkinson's disease. However, over time, the clinical response to levodopa becomes …
Levodopa–entacapone–carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidance
As Parkinson's disease (PD) progresses, treatment needs to be adapted to maintain
symptom control. Once patients develop advanced PD, an optimised regimen of oral and …
symptom control. Once patients develop advanced PD, an optimised regimen of oral and …
[HTML][HTML] The long-term impact of levodopa/carbidopa intestinal gel on 'off'-time in patients with advanced Parkinson's disease: a systematic review
Introduction Levodopa/carbidopa intestinal gel (LCIG; carbidopa/levodopa enteral
suspension) has been widely used and studied for the treatment of motor fluctuations in …
suspension) has been widely used and studied for the treatment of motor fluctuations in …
Continuous dopaminergic stimulation as a treatment for Parkinson's disease: current status and future opportunities
Levodopa‐induced motor complications remain an important source of disability for many
patients with Parkinson's disease. Substantial laboratory evidence indicates that motor …
patients with Parkinson's disease. Substantial laboratory evidence indicates that motor …
Levodopa challenge test: indications, protocol, and guide
A drug challenge test in Parkinson's disease, such as the levodopa challenge test (LCT), is
an easy and generally safe procedure, which has been used by clinicians for various …
an easy and generally safe procedure, which has been used by clinicians for various …
Parkinson disease (Japanese version)
H Homayoun - Annals of internal medicine, 2018 - acpjournals.org
Parkinson Disease (Japanese Version) Page 1 Annals of Internal Medicine® In the Clinic®
パーキンソン 病 パーキンソン病は進行性の運動および非運動障害を 引き起こすありふれた神経変性 …
パーキンソン 病 パーキンソン病は進行性の運動および非運動障害を 引き起こすありふれた神経変性 …
Levodopa: a new look at an old friend
CW Olanow, F Stocchi - Movement disorders, 2018 - Wiley Online Library
Levodopa is the most effective antiparkinsonian agent, but chronic treatment is associated
with the development of motor complications in the majority of patients with PD. Recent …
with the development of motor complications in the majority of patients with PD. Recent …